Visteon (NYSE: VC ) is expected to report Q4 earnings on Feb. 28. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Visteon's revenues will compress -7.8% and EPS will shrink -3.3%.
The average estimate for revenue is $1.71 billion. On the bottom line, the average EPS estimate is $0.88.
Last quarter, Visteon recorded revenue of $1.62 billion. GAAP reported sales were 15% lower than the prior-year quarter's $1.91 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.30. GAAP EPS of $0.28 for Q3 were 65% lower than the prior-year quarter's $0.79 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 7.9%, 60 basis points better than the prior-year quarter. Operating margin was 2.5%, 20 basis points better than the prior-year quarter. Net margin was 0.9%, 120 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $6.77 billion. The average EPS estimate is $2.95.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 47 members out of 52 rating the stock outperform, and five members rating it underperform. Among 27 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Visteon a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Visteon is buy, with an average price target of $54.40.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Visteon to My Watchlist.